Literature DB >> 16307017

The c-kit (CD117) sequence variation M541L, but not N564K, is frequent in the general population, and is not associated with CML in Caucasians.

S Krüger, M Emig, P Lohse, G Ehninger, A Hochhaus, H K Schackert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16307017     DOI： 10.1038/sj.leu.2404038

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

1.  Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.

Authors:  Sophie Laget; Lucile Broncy; Katia Hormigos; Dalia M Dhingra; Fatima BenMohamed; Thierry Capiod; Magne Osteras; Laurent Farinelli; Stephen Jackson; Patrizia Paterlini-Bréchot
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

2.  KIT Mutations Correlate with Higher Galectin Levels and Brain Metastasis in Breast and Non-Small Cell Lung Cancer.

Authors:  Avery T Funkhouser; Alexander M Strigenz; Bailey B Blair; Andrew P Miller; Jonah C Shealy; Joseph A Ewing; Julie C Martin; Christopher R Funk; William J Edenfield; Anna V Blenda
Journal:  Cancers (Basel)       Date:  2022-06-03       Impact factor: 6.575

3.  A V530I Mutation in c-KIT Exon 10 Is Associated to Imatinib Response in Extraabdominal Aggressive Fibromatosis.

Authors:  Jean-Emmanuel Kurtz; Irène Asmane; Anne-Claire Voegeli; Agnès Neuville; Armelle Dufresne; Valère Litique; Christine Chevreau; Jean-Pierre Bergerat
Journal:  Sarcoma       Date:  2010-03-17

4.  Monoclonal gammopathy-associated pure red cell aplasia.

Authors:  Neha Korde; Yong Zhang; Kelsey Loeliger; Andrea Poon; Olga Simakova; Adriana Zingone; Rene Costello; Richard Childs; Pierre Noel; Samuel Silver; Mary Kwok; Clifton Mo; Neal Young; Ola Landgren; Elaine Sloand; Irina Maric
Journal:  Br J Haematol       Date:  2016-03-21       Impact factor: 6.998

5.  Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technology.

Authors:  Armelle Dufresne; Laurent Alberti; Mehdi Brahmi; Sarah Kabani; Héloïse Philippon; David Pérol; Jean Yves Blay
Journal:  BMC Cancer       Date:  2014-08-29       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.